Sunovion Pharma to buy Canada's Cynapsus for $624 million
Troutman Sanders was mentioned in several publications, including Reuters, Boston Business Journal ,and The Boston Globe ,for the firm’s representation of Canada's Cynapsus Therapeutics Inc., which was acquired by Sunovion Pharmaceuticals Inc., a unit of Japan's Dainippon Sumitomo Pharma Co. Ltd., in a $624 million all cash transaction. The Troutman Sanders team included Tom Rose, David Meyers, Lisa Raines, Shona Smith, Nicole Edmonds, Daniel Howell, Mark Goldsmith, Heather Ettinger, James Schutz, Jeff Banish, Seth Ford, Mitch Portnoy and Dan Anziska.